American Journal of Cardiology
Volume 105, Issue 3 , Pages 343-351 , 1 February 2010

Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main Coronary Artery Disease (from a Two-Center Registry)

  • Si-Hyuck Kang, MD

      Affiliations

    • Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea
    • Drs S-H Kang and K-H Park contributed equally to the study.
    • ,
  • Kay-Hyun Park, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Seoul National University Bundang Hospital, Gyeonggido, Republic of Korea
    • Drs S-H Kang and K-H Park contributed equally to the study.
    • ,
  • Dong-Ju Choi, MD, PhD

      Affiliations

    • Department of Internal Medicine and Cardiovascular Center, Seoul National University Bundang Hospital, Gyeonggido, Republic of Korea
    • Corresponding Author InformationCorresponding author: Tel: (82) 31-787-7007; fax: (82) 32-787-7041
    • ,
  • Kyung Woo Park, MD, PhD

      Affiliations

    • Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea
    • ,
  • Woo-Young Chung, MD, PhD

      Affiliations

    • Department of Internal Medicine and Cardiovascular Center, Seoul National University Bundang Hospital, Gyeonggido, Republic of Korea
    • ,
  • Cheong Lim, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Seoul National University Bundang Hospital, Gyeonggido, Republic of Korea
    • ,
  • Ki-Bong Kim, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
    • ,
  • Hyo-Soo Kim, MD, PhD

      Affiliations

    • Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea

Received 15 July 2009 ,Revised 22 September 2009 ,Accepted 22 September 2009.

References 

  1. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation. 2004;110:e340–e437
  2. ACC/AHA/SCAI Practice Guidelines, February 21, 2006. Circulation. 2006;113:e166–e286
  3. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804–847
  4. Seung KB, Park D-W, Kim Y-H, Lee S-W, Lee CW, Hong M-K, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008;358:1781–1792
  5. Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–972
  6. de Lezo JS, Medina A, Pan M, Delgado A, Segura J, Pavlovic D, et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J. 2004;148:481–485
  7. Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005;111:1383–1389
  8. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006;113:2542–2547
  9. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol. 2006;97:1597–1601
  10. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2006;47:864–870
  11. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol. 2006;98:54–59
  12. Rodes-Cabau J, DeBlois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 2008;118:2374–2381
  13. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: long-term CASS experience. Circulation. 1995;91:2325–2334
  14. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  15. Thygesen K, Alpert JS, White HD Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653
  16. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
  17. Takaro T, Peduzzi P, Detre KM, Hultgren HN, Murphy ML, van der Bel-Kahn J, et al. Survival in subgroups of patients with left main coronary artery disease: Veterans Administration Cooperative Study of surgery for coronary arterial occlusive disease. Circulation. 1982;66:14–22
  18. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319:332–337
  19. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563–570
  20. Park SJ, Park SW, Hong MK, Cheong SS, Lee CW, Kim JJ, et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol. 1998;31:37–42
  21. Marso SP, Steg G, Plokker T, Holmes D, Park SJ, Kosuga K, et al. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the Ultima experience) (Unprotected left main trunk intervention multi-center assessment). Am J Cardiol. 1999;83:1513–1517
  22. Park SJ, Park SW, Hong MK, Lee CW, Lee JH, Kim JJ, et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol. 2003;91:12–16
  23. Taggart DP, Kaul S, Boden WE, Ferguson TB, Guyton RA, Mack MJ, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol. 2008;51:885–892
  24. Sianos G, Morel M-A, Kappetein AP, Morice M-C, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroInterv. 2005;1:219–227
  25. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, et al. Cyphering the complexity of coronary artery disease using the Syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol. 2007;99:1072–1081
  26. Chieffo A, Park S-J, Meliga E, Sheiban I, Lee MS, Latib A, et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J. 2008;29:2108–2115
  27. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol. 2008;51:2212–2219
  28. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
  29. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol. 2006;47:871–877

 This study was supported by grant A062260 from the Innovative Research Institute for Cell Therapy, Department of Internal Medicine, Seoul National University/Cardiovascular Center, Seoul, Republic of Korea, and grant 0412-CR02-0704-0001 from the Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea, sponsored by the Ministry of Health and Welfare, Republic of Korea.

PII: S0002-9149(09)02407-2

doi: 10.1016/j.amjcard.2009.09.036

American Journal of Cardiology
Volume 105, Issue 3 , Pages 343-351 , 1 February 2010

Article Tools

* Image Usage & Resolution